Serebruany, Victor
Golukhova, Elena
Article History
First Online: 10 August 2017
Competing interests
: V.S. is listed as an inventor for the issued US patent 'Treating vascular events with statins by inhibiting PAR-1 and PAR-4′ (7,842,716) and 'Method for treatment of platelet activity with E5555' (USN 61/080,791); assigned to Eisai. He received compensation for the issued U.S. patent 11/996,380 'Use of PAR-1/PAR-4 inhibitors for treating and preventing vascular diseases' on prasugrel assigned to Lilly. He received consultant and lecture fees from Aralez, AstraZeneca, Bayer, Daichii Sankyo, Lilly, Merck, and Sanofi. E.G. declares no competing interests.